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INTRODUCTION 
 
  Retinal Vasculitis is a non specific immunologic reaction of retinal 
arterioles or venules to various antigenic stimuli that may occur in many 
different systemic and local disease states. 
 
It may be defined, however, to be present when there are vascular 
leakage and staining of vessel walls on fundus fluorescein angiography, with or 
without clinical appearance of fluffy, white perivascular infiltrates in an eye 
with evidence of inflammatory cells in the vitreous body or aqueous humor.  
 
 Retinal vasculitis may or may not be symptomatic. Inflammation of 
peripheral retinal blood vessels is typically asymptomatic, but inflammation 
involving macular retinal blood vessels frequently causes decreased visual 
acuity and focal scotomas. Associated vitreous inflammatory cells can give rise 
to floaters.  
 
The signs of vascular sheathing or cuffing can be found in inflammatory 
vascular disorders as well as in ischemic vasculopathies without inflammation. 
These two conditions should not be confused, as the approach to the diagnosis 
is different. If vascular sheathing is accompanied by vitreous cells, adjacent 
intra retinal edema, or infiltrates, it is more likely to be inflammatory in orgin.  
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Fundus fluorescein angiography is useful in evaluating the severity and 
extent of disease. Mildly inflamed vessels usually only show staining with 
fluorescein, whereas in more severe inflammation, dye leakage occurs as well. 
In occlusive vasculitis, capillary fallout is seen. If untreated, neovascularization, 
vitreous hemorrhage, and tractional retinal detachment may ensue51.     
 
History 
 In 1887 Wads Worth was first to describe the clinical picture of retinal 
periphlebitis, 1873 Perls performed histological examination of periphlebitis in 
case of T.B. In 1880 Henry Eales described the syndrome and he associated 
epistaxis and constipation with recurrent Vitreous hemorrhage in later paper, 
excluded known systemic disease including, diabetes, clotting abnormalities, 
blood dyscariasis, syphilis. In beginning of early century relation with T.B. 
suggested. 
 
 Duke – Elder regarded Eales disease as clinical manifestation of 
inflammatory retinal vessel occlusion or periphlebitis. Eales disease occurs 
frequently in India finding difficult to distinguish this condition from other type 
of retinal Vasculitis. 
 
 
 
 3
DISORDERS ASSOCIATED WITH RETINAL 
VASCULITIS26 (CLASSIFICATION) 
 
I. Infections Associated with Retinal Vasculitis    
Tuberculosis, Syphilis, Borreliosis – Toxoplasmosis, Herpes virus, 
Cytomegalo Virus, Acute Retinal Necrosis, Candidiasis, Leptospiroisis, 
Brucellosis, Cat scratch disease, Rickettsia, Epstein Bar virus, Whipple’s 
disease, HIV, Rift valley fever virus.     
 
II. Vasculitis secondary to systemic Autoimmune disease  
Behcet Disease, Crohns Disease, Rheumotaid Disease Buerger’s disease, 
Sjogren’s syndrome A antigen. HLA B27 associated uveitis Sarcoidosis,  
 
III. Retinal Vasculopathy in systemic Vasculitis   
Systemic Lupus Erythematosus, Wegeners Granulomatosis, Poly 
Arteritis Nodosa,  
 
IV. Vasculitis secondary to Ocular disorder 
1. Eales disease, Idiopathic retinal Vasculitis, pars planitis, bilateral 
iridocyclitis with retinal capillaritis, frosted branch angitis, bird shot 
retinochoroidopathy, Idiopathic retinal Vasculitis aneurysm and 
Neuroretinitis, Idiopathic recurrent branch. Retinal Arteriolar 
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Occlusion, Sympathetic Ophthalmia, Primary ocular disease, Vogt – 
Koyanagi – Harada Syndrome  
 
V. Retinal Vasculitis Associated with Neurologoic Disorders  
Multiple Sclerosis, Isolated central Nervous system angitis, Micro 
Angiopathic encephalopathy, Hearing loss and Retinal arteriolar occlusion 
isolated central nervous system angitis.     
 
VI. Drug Induced – Retinal Vasculitis 
VII. Retinal Vasculitis secondary to malignancy  
VIII. Miscellaneous cause of Retinal Vaculitis    
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Retinal vascular anatomy  
There are two sources of blood supply to the retina: the central retinal 
artery and the choroidal blood vessels. The choroid receives the greatest blood 
flow (65-85%) (Henkind et al., 1979) and is vital for the maintenance of the 
outer retina (particularly the photoreceptors) and the remaining 20-30% flows 
to the retina through the central retinal artery from the optic nerve head to 
nourish the inner retinal layers. The central retinal artery has 4 main branches in 
the human retina 
 
The arterial intraretinal branches then supply three layers of capillary 
networks i.e. 1) the radial peripapillary capillaries (RPCs) and 2) an inner and 
3) an outer layer of capillaries. The precapillary venules drain into venules and 
through the corresponding venous system to the central retinal vein 
The radial peripapillary capillaries (RPCs) are the most superfical layer 
of capillaries lying in the inner part of the nerve fiber layer, and run along the 
paths of the major superotemporal and inferotemporal vessels 4-5 mm from the 
optic disk (Zhang, 1994). The RPCs anatomose with each other and the deeper 
capillaries. The inner capillaries lie in the ganglion cell layers under and 
parallel to the RPCs. The outer capillary network runs from the inner plexiform 
layer to the outer plexiform layer through the inner nuclear layer (Zhang, 1974). 
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A ring of blood vessels in the macular area around a blood vessel and 
capillary-free zone 450-600mm in diameter, denoting the fovea. The macular 
vessels arise from branches of the superior temporal and inferotemporal 
arteries. At the border of the avascular zone, the capillaries become two layered 
and finally join as a single layered ring. The collecting venules are deeper 
(posterior) to the arterioles and drain blood flow back into the main veins.  
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It is worth identifying retinal vessel to correlate the retinal features of 
systemic Immune diseases with size of vessels involved42. 
 
Vessel involved Disease Retinal Features 
Muscular 
arteries   
Poly arteritis 
Nodosa   
Cotton wool spots, retinal edema, 
Hypertensive changes   
Medium to 
small arteries  
Wegeners 
granulomatosis   
Cotton wool spots, arteriolar occlusion 
Small arteries  Systemic lupus 
erythematosus  
Cotton wool spots, retinal edema, 
Haemorrhage   
Capillaries  Whipple’s disease  Haemorrhage, Exudate, capillary 
occlusion  
Veins  Behcet’s disease  
 
Sarcoidosis  
 
Multiple sclerosis   
Infiltrate branch retinal vein occlusion, 
macular edema neovascularization  
Periphlebitis, venous sheathing, 
choroidal Granuloma, neo 
vascularization.   
Venous sheathing, macular edema,  
neovascularization  
Arteries and 
Veins  
Crohn’s disease  
Poly chondritis  
Vascular occlusion  
Exudate with Haemorrhage  
Miscellaneous   Ankylosing 
spondylitis  
HLA – B 27 
positive  
Macular edema, vitritis, diffuse micro 
vascular leakage   
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PATHO PHYSIOLOGY AND IMMUNOLOGY 
RETINAL VASCULITIS IS BELIEVED AS IMMUNOLOGICAL 
MEDIATED CONDITION26 
Retina contain number of tissue-specific antigen, one of which Retina-S-
antigen. Ocular inflammation induced by S-antigen is marked retinal Vasculitis 
accompanied by focal mononuclear cell infiltrates and necrosis of photo 
receptor cell layer. Patient have systemic inflammatory disease could develop 
retinal Vasculitis because of presence of circulating immune complex, non 
organ specific auto immune or abnormal white cell functions. Isolated retinal 
Vasculitis may be an organ specific auto immunological disease of retina. 
 
MAJOR COMPONENT IS CELL MEDIATED IMMUNITY 
 Presents of CD4+ T cell as predominant cell in vascular lesion of eye, 
supports assumption of retinal Vasculitis is cell mediated immunity.  
(a) Adhesion – Adhesion interaction molecule (selection, integrin) enables 
leukocyte adherence to vascular endothelium (Carbohydrate). 
Chemokine also plays an important role. 
(b) Tethering and rolling – Activated endothelium to express P-selecting 
and E-selecting that interacts with carbohydrate moieties of leukocyte – 
slow their speed and roles on endothelium. 
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(c) Latching and activation – Lymphocyte function-associated adhesion 
molecule 1(LFA-1) binds to endothelial cell ligand called inter cellular 
adhesion molecule (ICAM-I, II, III)-gives an stronger attachment. 
Other antigens are very late antigen (VLA) with vascular cell adhesion 
molecule (VCAM). 
(d) Migration – activated leukocytes flatten to the endothelium, affinity of 
leukocyte integrin is unregulated and expression of late binding protein 
occurs it initiates migration through endothelium and basement 
membrane to from peri vascular cuff of inflammatory cells. 
 
HUMORAL IMMUNITY AND IMMUNE COMPLEX: are still 
controversy 
      Although type III hyper sensitivity is a mechanism of tissue damage is 
systemic vasculitis. 
 
 On presence of dominating CD4+, T cell respond retinal vasculitis may 
also have a humoral response and this may have an Immune regulatory function 
perhaps influenced by Immune complex formation.  
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SYMPTOMS AND SIGNS10,18,46 
 
1. Symptoms:        
• Inflammation of peripheral vessels may be completely 
asymptomatic  
• Painless blurring or loss of vision – due to vitreous haemorrhage   
• Large Scotoma corresponds to area of ischemia  
• Floaters  
• In eales disease sudden loss of vision to vitreous hemorrhage. 
• Sign of systemic involvement like Oro-genital ulcer, Arthritis, 
skin rash, respiratory and neurological symptoms   
2. Signs:   
(a) Anterior Uveitis can be seen in 1/3rd of cases  
1. Circumcorneal (ciliary) congestion – in associated with glaucoma   
2. Keratic precipitates  (a) Endothelial dusting  
(b) Medium –size Keratic precipitates 
(c) Large Keratic precipitates 
(d) Old Keratic precipitates 
3. Cells are indicative of active inflammation  
(a) Aqueous cells  
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(b) Anterior vitreous cells  
4. Aqueous flare-faint: just detectable   = + 1 
       Moderate: Iris details clear  = + 2 
       Marked Iris details Hazy  = + 3 
      Intense with Fibrinous exudates= + 4 
5. Iris nodules-are features of granulomatous inflammation. Koeppe’s 
nodule and Bussaca nodule.  
(b) Cellular infiltrations of vitreous as seen in all cases. 
(c) Inflammatory cells or snow balls in inferior vitreous cavity. 
 
HALL MARK – VASCULAR CHANGES  
 In active phase-Sheathing of vessel, fluffy white cuffing around vessel 
throughout vessel or like skip lesion, sheathing most often in veins then 
arterioles. 
 
 In chronic phase-sheathing seen in peripheral retina and not associate 
with flourescein leakage from periphlebitis. 
 
 An extreme form of exaggerated sheathing of vessels gives of clinical 
picture that resemble tree branches in winter called FROSTED BRANCH 
ANGITIS. 
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 In some conditions like sarcoidosis discrete waxy nodule are seen on the 
retinal vessel, in human T cell lymphoma virus type 1 (HTLV 1) – 
characteristic gray white granular deposit on retinal vessel. 
 
 In addition to vascular changes retinal edema is common and may 
proceed vascular cuffing, deep retinal infiltrate in some patient. 
 
 In Retinal-vascular occlusion associated with Behcets disease leads to 
retinal hemorrhage, Cotton wool spot, pallor in areas of retinal Ischemia. 
Vessels in these areas become sclerotic attenuated. Retinal Neovascularisation 
in 16 – 40% cases of retinal vasculitis along with vitreous hemorrhage.  
 
 
 
 
 
 
 
 
 
 
 
 
 13
RETINAL VASCULITIS IN OCULAR DISEASE 
 
IDIOPATHIC RETINAL VASCULITIS31,49,61   
 Occurs in young adults and causes blindness  
Ophthalmoscope feature shows sheathing of retinal vessels and vitritis.  
 Fundus flourescein angiography reveal areas of clinically invisible 
disease, confirms the diagnosis in the absence of systemic condition finding by 
history and examination.  Full blood count, sedimentation rate SEROLOGY 
FOR SYPHILLIS, X-RAY CHEST.  
 
Visual outcome variable and depends on presence of retinal ischemia. 
Ischaemic group having vision of 6/60 or worse on compare with non ischemia. 
In a retrospective study, 59% chance of developing systemic disease, major 
event is cerebro vascular accident. So blood pressure and lipid profile are 
important and also history of smoking.  
 
EALE’S DISEASE12,20 
 Henry Eales (1880-1882) was the first to describe a clinical syndrome of 
recurrent retinal and vitreous hemorrhages in apparently healthy young men.  
 
 Classifically manifest as obliterative periphlebitis anterior to equator 
involving multiple quadrants with progression posteriorly. Eales stimulate as 
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Idiopathic Branch Retinal Vein Occlusion do not occur at AV crossing site and 
may / may not be associated with Cotton Wool Spot. 
 
CLINICAL PRESENTATION    
Classically the presenting feature of the Eales disease is repeated 
vitreous hemorrhage patients compliant of sudden appearance of floating spots, 
cobwebs, cloudy vision, or simply reduced vision. Vision often improves with 
time before a repeat hemorrhage affects vision again. The recovery of vision 
usually becomes less and less complete with recurrent episodes. Finally, the 
patient may be left with no useful vision. The gross loss of vision may be due to 
unresolving vitreous hemorrhage or such complications as traction retinal or 
macular detachments. Often a routine examination of the contra lateral eye 
reveals evidence of present or past phlebitis. A normal contra lateral eye, in the 
course of time, may develop the disease. At the time to presentation the contra 
lateral eye was found to be affected in more than 50% of cases. Ultimately, the 
involvement becomes bilateral in 80% to 90% of cases. 
 
All patients do not present in this classical form, however. Some present 
themselves with sudden gross loss of vision that does not clear for years, the 
result of massive vitreous hemorrhage during the initial stage of acute phlebitis. 
Others complain of reduced or blurred vision because of macular edema, 
hemorrhages, or concomitant macular infarction. 
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A sizeable number of patients are not aware of the disease because the 
lesions are peripheral. The signs of disease are noted during routine fundus 
examinations. Although phlebitis is less common among women, when it does 
appear it is usually much more severe and difficult to control, and the post-
treatment results are less satisfactory. Although one often observes uveitis 
(Choroiditis), papillitis, or Arteritis associated with phlebitis, it is phlebitis that 
is central to the clinical manifestation of Eales disease. 
     
PATHOPHYSIOLOGY 
 The basic pathology of Eales disease is retinal phlebitis multiple 
branches of central retinal vein are inflamed, causing multiple inflammatory 
BRVOs. Occassionally, the central retinal vein may be inflamed and occluded 
with or without associated inflammation of branch retinal veins, resulting in 
inflammatory CRVO. A CRVO in a young adult man who is neither 
hypertensive nor diabetic, and who has no signs of arteriosclerosis, would 
suggest phlebitis. Dramatic response to oral corticosteroids could help confirm 
the diagnosis. The severity and the course of phlebitis vary widely. 
 
ACUTE COURSE 
 An acute and rapid course results in sudden and complete occlusion of 
the retinal veins, which could lead to subhyaloid or vitreous hemorrhage. When 
a large-caliber retinal branch vein is suddenly occluded, a massive vitreous 
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hemorrhage results that does not clear for months or years. The diagnosis is 
made on the basis of findings in the contra lateral eye and by excluding other 
causes. On the other hand, when a smaller caliber peripheral venule hemorrhage 
is relatively less massive and clears with time. Occasionally, more than one 
peripheral venule becomes involved in sequence, causing RVH during stages of 
acute phlebitis.  
 
NONACUTE COURSE 
 Here phlebitis can be very mild and chronic, causing little or no 
noticeable vascular decompensation in the form of retinal hemorrhage or retinal 
edema.  
 
SUBACUTE COURSE 
 Most cases fall into this category. The retinal sector being drained by the 
inflamed branch shows retinal hemorrhages and edema. There could be cotton 
wool spots and dark blot hemorrhages, indicating retinal ischemia. Peripheral, 
segmental ischemia owing to inflammatory BRVO leads to NVE originating 
just proximal to the site of inflammation and occlusion. In cases with multiple 
venous branch involvement and extensive peripheral ischemia one would 
expect NVD along with multiple peripheral NVE. Often one finds the classical 
sea-fan neovascular lesion in the retinal periphery. 
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 Because retinal ischemia in cases of multiple BRVO can be well defined 
and limited to the territories of venous drainage, selective retinal ablation by 
scatter photocoagulation or cryoablation need to be restricted to these defined 
areas. Indiscriminate panretinal photocoagulation has no place in the 
management of Eales disease, even in cases with NVD. 
 
 Some areas show marked capillary engorgement, which sometimes leads 
to small RVH. Sometimes one can demonstrate multiple microaneurysms. 
 
 The inflamed veins present varied pictures. There could be massive 
exudation over large tracts of the vein, causing complete occlusion of vein 
segments. The vitreous may be turbid. When inflammation subsides, some of 
the veins would show complete destruction of the vein segment on FA. Some 
cases show nodular formation over the inflamed veins. These cases may be 
inflamed veins. These cases may be presumed to be cases of tubercular 
phlebitis.  
 
Drugs for tuberculosis have been found to be effective. In less severe 
cases, variable degrees of infiltration in and around the veins in segmental 
fashion can be seen. These segments, during the stage of active inflammation, 
show a pale white, fluffy, finely irregular outline. Fluorescein angiography 
shows delayed filling, prolonged circulation time, and a narrowed lumen. In the 
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late phases, the inflamed vein segments may show dye staining and even dye 
leakage through the venous walls. 
 
 On resolution of phlebitis, the inflamed segments show parallel 
sheathing, kinking, or looping owing to gliosis. Often one finds choriorentinal 
scars under the inflamed segment. The chorioretinits seems to be secondary to 
phlebitis. Even on sometimes demonstrate delayed circulation in the area 
involved.  
 
Healing and the Process of Circulatory Compensation  
 Phlebitis subsides with time. Treatment with anti inflammatory and other 
drugs accelerates the process. The venous obstruction tends to get relieved, with 
the lumen opening up to a variable degree. Some acute cases, however, show 
permanent destruction of vein segments. Veno-venous capillary develop from 
obstructed to normal territory. These capillaries dilate and show tortuosity, one 
of the most common findings in Eales disease. Occasionally the dilated 
capillaries shows macro aneurysm that could leak fluorescein. Rarely one may 
see large shunt vessels. 
 
 The retina with compromised circulation and ischemia gradually 
becomes atrophic, with reduced circulation and reduced venous return. The 
arterioles look reduced in caliber and the venous engorgement disappears. The 
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stimulus for vascular proliferation disappears. The new vessels, which had 
developed in response to retinal ischemia, now tend to regress with reduced 
vascularity.  
 
The regressing new vessels lead to glial proliferation which, in turn, 
causes several serious complications. The contracting glial tissue may detach or 
distort the macula and cause macular degeneration, macular cyst, or macular 
holes. These may cause traction retinal tears leading to rhegmatogenous retinal 
detachment. Sometimes, the macula may get covered with thick glial tissue, 
compromising vision.  
 
 What happens as a natural course of the proliferative retinopathy is 
achieved through uncontrolled selective retinal ablation by scatter 
photocoagulation and retinal cryoablation. Anchoring the neovascular lesions to 
the underlying retina and choroids by strategically placed photocoagulation 
marks, before the neovascular lesions are made to regress by scatter 
photocoagulation, would avoid most of the traction related complications.  
 
INVESTIGATIONS 
Flourescein Angiography   
Valuable in revealing the degree of retinal capillary Non perfusion and 
presence of Neovascularisation as a guide to laser. 
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 The inflamed venous walls stain with narrowed lumen and may show 
some swelling and dilation distal to the site of inflammation or even frank 
extravasation. On the other hand, parallel sheathing, caused by gliosis after the 
inflammation has subsided, does not show this feature. In most cases, the 
segmental venous inflammation produced varying degrees of venous occlusion. 
The lumen may be narrowed or even closed. 
 
 Fluorescein angiography study the course of this vascular disease both 
structurally and functionally. Although cases of proliferative retinopathy are 
being treated by selective retinal ablation with scatter photocoagulation and 
cryoabalation, the regression of new vessels can be monitored with extreme 
precision by Fluorescein Angiography. 
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PARS PLANITIS  
 An intermediate Uveitis, usually bilateral and varies from mild 
inflammation to blinding condition Ocular manifestation include variable 
number of spill over anterior chamber cells, Vitreous cells, snow balls, and 
snow banks. Inferior peripheral retinal phlebitis with retinal venous sheathing is 
common with chronic inflammation cystoid macular edema develops. Ischemia 
from retinal phlebitis, combined with angiogenic stimuli from intraocular 
inflammation can lead to neovascularization, results in vitreous haemorrhage, 
contract and lead to peripheral tractional and rhegmatogenous retinal 
detachment. 
 
Differential diagnosis: syphilis, lyme uveitis, sarcoidosis          
Treatment: Should be directed to wards treating the underlying cause of 
inflammation if possible. Treatment is usually implemented if visual acuity 
6/12 or worse or if cystoid macular edema present. Otherwise no treatment 
required  
Step I: Periocular corticosteroid constitute first line of therapy. 
 Triamcinolone / methyl prednisolone may be used. Injections are usually 
repeated every 2-3weeks. Until four injections have been administered. 
 If local not effective, systemic steroids were used, and reserved for more 
severe or bilateral cases. 
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Step II: If corticosteroid fails peripheral ablation of the pars plana snow 
bank with cryo theraphy or indirect laser photo coagulation should be 
performed. 
Step III: If cryo theraphy fails and systemic immuno suppressive is 
contraindicated or not desired pars plana vitrectomy with induction of posterior 
hyaloid separation and peripheral laser photocoagulation to pars plana snow 
bank performed. 
Step IV: If all other therapeutic failed systemic immuno modulating 
agents are used.             
 
IDIOPATHIC RECURRENT BRANCH RETINAL ARTERIOLAR  
OCCLUSION  
Common in middle age groups recurrent branch retinal arteriolar 
occlusion. No inflammatory disease or evidence of embolism  
Focal perivascular sheathing and flourescein angiography shows 
multiple segment arteriole staining. Pre retinal neovascularisation occurs in area 
of ischemia. No systemic cause found but 50% patient has vestibule or transient 
sensory motor symptoms or both.    
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PRIMARILY OCULAR DISEASE  
 In bird shot retinopathy retinal vasculitis of venules is a prominent and 
consistent feature. It may present as idiopathic retinal vasculitis with the 
development of characteristic focal cream coloured lesion.  
 
 
RETINAL VASCULITIS AND NEUROLOGICAL DISEASE  
Multiple sclerosis26 
 Ocular inflammatory signs in multiple sclerosis are iritis, intermediate 
uveitis, posterior uveitis, periphlebitis, optic neuritis. In most cases periphlebitis 
is subtle peripheral, and of no visual consequence, in some cases leads to 
occlusive vasculitis, ischemia, retinal neovascularisation.  
 
 Patches of fluffy peri vascular cuffing represent areas of active disease, 
whereas sclerotic whitening of venular wall with no leakage is chronic, 
periphlebitis due to lympho plasmacytic infiltrate, occasionally with 
granulomatous component.  
 25% of retinal vasculitis develop multiple sclerosis particularly if they 
are female and carry the HLA b27/HLA DR2 alleles.  
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INFECTIOUS ASSOCIATED WITH RETINAL VASCULITIS  
Bacteria  
TUBERCULOSIS51 
Tuberculosis (TB) of the retina is always hematogenously derived from a 
lesion elsewhere in the body, diagnosed or occult. The most common 
presentation of retinal involvement is periphlebitis. Isolated retinal periphlebitis 
is rare, but may be the presenting sign in disseminated tuberculosis. It is often 
accompanied by a moderate vitreous infiltrate, macular star, and retinal 
hemorrhage. It may result in branch or central retinal vein occlusion, often with 
peripheral retinal closure, leading to new vessel formation and vitreous 
hemorrhage. 
 
Retinal vasculitis has also been reported following a Mantoux test. 
Tuberculosis retinal vasculitis is not characteristic and may be misdiagnosed 
unless choroidal tubercles are also present. It should be suspected in the 
presence of florid retinal vasculitis with marked capillary closure with a 
relatively mild degree of vitritis. Histology of the retina shows granulomatous 
lesions surrounding retinal vessels.  
 
 The definitive diagnosis of intraocular TB is often difficult, as it requires 
the identification of Mycobacterium tuberculosis. It is hazardous to obtain 
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biopsy material from the eye, however, and smears and cultures from aqueous 
humor or vitreous give a low yield. Polymerase chain reaction can be used to 
amplify mycobacterial DNA from clinical samples, but it faces the risk of false 
positive results. A 2-week therapeutic trail of isoniazid is controversial, 
especially with the increasing prevalence of drug-resistant strains of M. 
tuberculosis.   
 
A diagnosis of ocular TB, even in the presence of systemic TB, therefore 
often has to be presumed. Systemic disease may be detected by a chest 
roentgenogram or positive sputum culture. It is important to have a high index 
of suspicion in patients with Asiatic origin, those with a history of contact with 
TB, or when the Mantoux response is strongly positive (usually more than 15 
mm induration at 72 hours). 
 
 The vasculitis responds to anti-TB therapy, and it should be given in the 
absence of active systemic disease if tuberculosis ocular disease is strongly 
suspected, as reactivation of the systemic illness may occur with systemic 
steroid therapy for retinal vasculitis. Neovascularization of the disc or retinal 
periphery may require panretinal photocoagulation.  
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SYPHILIS51  
Syphilis is caused by the spirochete, Treponema pallidum. It is primarily 
a sexually transmitted disease, but it can also be spread by transfusion of fresh 
blood, or by accidental contact with an infected lesion. The ocular 
manifestations of syphilis are variable and may mimic any from of intraocular 
inflammation. Retinal vasculitis usually occurs in association with 
Chorioretinitis, but primary leutic retinal vasculitis is rare and usually involves 
the arteries with or without occlusion. Isolated periphlebitis and concomitant 
involvement of artery, vein have also been reported. Leutic vasculitis is 
commonly associated with severe vitritis, intraretinal and pre retinal 
hemorrhages, and exudates that are occasionally recurrent or massive. 
Neovascularization and retinitis proliferans may occur, resulting in narrowing 
and ensheathing of retinal vessels. 
 
 The pathogenic spirochetes cannot be routinely isolated in the 
laboratory; hence the diagnosis of syphilis is usually based on a history of 
exposure, clinical findings, and the results of serologic tests. The serologic tests 
for syphilis are the mainstay of diagnosis when there are no lesions to be 
examined by direct microscopy. These tests can be divided into two groups: 
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(1) Those that detect antibody to cardiolipin – lecithin-cholesterol antigen 
(non treponemal tests), such as Veneral Disease Research Laboratory 
(VDRL) and RPR. 
(2) Those that detect antibody against treponemal antigens, such as FTA – 
ABS and T. pallidum hemagglutination assay. False-positive results can 
occur with both types of tests. Nontreponemal tests are best suited for 
general screening with any positive result confirmed with a treponemal 
test. Nontreponemal tests are also used to monitor treatment because 
their titers decrease following effective therapy, whereas FTA – ABS 
usually remains positive throughout the lifetime of both treated and 
untreated patients. The serologic tests for syphilis are probably less 
reliable when co infection with HIV exists. Penicillin G is the drug of 
choice for treatment is presumptive based on the resolution of clinical 
findings and the demonstration of a declining serologic titer.  
 
BORRELIOSIS (LYME DISEASE)51 
 Lyme disease is also caused by a spirochete, Borrelia burgdorferi. It is 
transmitted by the Ixodidae ticks, and patients may develop acute or chronic 
multisystem inflammation with variable manifestations, including erythema 
migrans, oligoarthritis, and neurologic and cardiac abnormalities. 
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 Retinal vasculitis may present during both the disseminated and the late 
stages of the disease. Vessel sheathing and occlusion, intraretinal hemorrhages, 
vitreous cells, and disc and peripheral neovascularization with vitreous 
hemorrhage or vitreoretinal traction may develop. Fundus fluorescein 
angiography may reveal delayed filling of the retinal arterioles and venules with 
staining of the vessel wall. 
 
 Serologic tests, such as ELISA and the immunofluoresence antibody test 
have limited sensitivity, long latency to response, decreased responsivity after 
antibiotic treatment, and a cross-reactivity with syphilis and other infections. 
Therefore, in suspected Lyme disease, VDRL and FTA- ABS should be 
checked along with Lyme ELISA. A rise in Lyme IgG titers supports the 
diagnosis of active disease, and may be used to monitor the response to 
treatment. Polymerase chain reaction testing of the vitreous and CSF may be 
positive. 
 
 The ocular disease responds to antibiotic therapy, such as oral 
tetracycline in adults, or penicillin V in children. Erythromycin can be used in 
penicillin allergy. Intravenous ceftriaxone 1 g to 2 g/day for 14 days or longer is 
recommended for Stage II Lyme disease. The use of corticosteroids is 
controversial. 
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BRUCELLOSIS  
 Brucella infection is transmitted by direct contact with infected animals 
but mostly by consumption of unpasteurized dairy product.  
 
 Uveitis is the most common manifestation. Inflammation may cause, 
granulomatous / Nongranulomatous anterior uveitis, retinitis, Choroiditis and 
also retinal vasculitis.  
 
LEPTOSPIROSIS  
 
• Affect eye in both immune and septicemic  stages of the disease  
• 2week- 1year after infection  
• Associated with extensive vitreous membrane periphlebitis, 
Choroidits, Parsplanitis and disc edema.  
 
PROTOZOAL 
TOXO PLASMOSIS26 
 Perivasculitis is caused by arthus – type reaction  
• Veins show continuous sheathing over long segment with 
narrowing of vessels near acute lesions or segmental cuffing of 
vessels adjacent to active retinitis involved. But sheathing also 
occur away from the lesion.  
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• Focal periarterial exudate or plaque –called as kyrieleis arteriolitis 
are not associated with vascular leakage or obstruction. Vasculitis 
quickly resolves with resolution of disease and disappearance of 
antigen.  
 
VIRAL RETINAL VASCULITIS   
HIV retinopathy 
HIV retinopathy is the most common ocular manifestation, occurring in 
40-60% of HIV-positive patients and recognized in 89% of autopsies. 
Histopathological findings resemble those of diabetic retinopathy, with pericyte 
necrosis, endothelial cell swelling, and thickening of basement membrane. 
Hypothesis for vascular injury include immunoglobin deposition, endothelial 
cell infection by HIV, and hyperviscosity secondary to increased red cell 
aggregation, fibrinogen, and increased polymorphonuclear leukocyte rigidity. In 
the anterior segment, these changes are seen as dilated and tortuous segments of 
vessels.  
 
Occurring in up to 50% of individuals with HIV, cotton wool spots are 
the most common findings in patients with AIDS. These occur primarily in the 
posterior pole in the peripapillary region. Cotton wool spots seen in individuals 
with HIV are identical to those seen in other conditions. Cystoid bodies 
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represent swollen axons caused by interruption of axoplasmic flow. Although 
ischemia is the most common cause of cotton wool spots, any interruption of 
axoplasmic flow leads to the formation of cotton wool spots. Accumulation of 
axoplasmic debris in the nerve fiber layer leads to the appearance of cotton 
wool spots.  
 
Retinal hemorrhages develop in up to 30% of patients with AIDS. A 
variety of hemorrhages are seen, including flame shaped, dot-blot, or peripheral 
punctate hemorrhages.  
 
Clinically, HIV retinopathy is a sign of a low CD4+ count (usually <50 
cells/micro litre) and requires close screening (every 3 months) to look for other 
manifestations that can occur with such a low CD4+ count, such as 
cytomegalovirus (CMV) retinitis.  
 
Cytomegalovirus  
CMV retinitis is the most common ocular infection in patients with 
AIDS, occurring in the pre-HAART (highly active antiretroviral therapy) era in 
20-40% of patients. The median onset from the diagnosis of AIDS is 9 months, 
although it has been reported as late as 5 years. The median time to progression 
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was 47-104 days, with a mean survival after diagnosis of 6-10 months. The risk 
for CMV retinitis increases with lower CD4+ counts.  
Intimate exposure to infectious sources of virus (i.e., blood, urine, saliva, 
other secretions) sometimes leads to hematogenous seeding of CMV-infected 
monocytes to the retina. HIV-damaged capillary endothelial cells in the retina 
also may facilitate the entry of infected monocytes is to the retina. Infrequently, 
contiguous spread from the optic nerve may also occur.  
CMV retinitis is a full-thickness retinal infection that originates 
peripherally as perivascular, opaque white granular areas of necrosis associated 
with hemorrhages. Infiltrates are composed of retinal edema, infected retinal 
cells, and cellular necrosis affecting all layers of the retina. Vitritis is typically 
minimal, although reconstitution of the immune system with HAART can lead 
to more vigorous vitritis. Intranuclear and intracytoplasmic DNA-positive viral 
inclusions are found within necrotic cytomegalic cells. Untreated, CMV 
retinitis progresses at a median rate of 24 m/d. Of those patients with CMV 
retinitis, 35% may present with bilateral disease, and up to 52% will eventually 
develop bilateral disease.  
Contiguous spread is more common than skip lesions. Active virus is 
present in the advancing edge, with a necrotic retina remaining in its wake. In 
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clinical studies, progression has been defined as the movement of disease by 
750 mm along a 750 mm-wide front or as the development of new CMV 
lesions. Retinal damage leads to a corresponding absolute scotoma. The thin 
atrophic retina is susceptible to breaks and rhegmatogenous retinal detachments 
can occur within 3-6 months of diagnosis. The median time to retinal 
detachment is 18.2 months. Before HAART, retinal detachments occurred in 
one third of affected eyes. The larger the area of involvement, the greater the 
risk of retinal detachment. Retinitis involving 25-50% of the retina conferred a 
risk 5-6 times greater of retinal detachment than that observed with only 10% 
involvement. Visual loss is primarily due to retinal necrosis and retinal 
detachment. Macular edema, CMV papillitis, and neuroretinitis also contribute 
to visual loss.  
Several clinical forms exist. In the fulminant form, diffuse retinal 
hemorrhage with a whitened necrotic retina similar to a retinal vein occlusion is 
seen. Patients are often aware of vision loss. The indolent form presents with 
granular lesions in the peripheral retina often with little or no associated 
hemorrhage. Patients may notice floaters, or they may be asymptomatic. The 
third uncommon presentation is frosted branch angiitis. Routine screening with 
dilated eye examinations has been recommended at 3-month intervals in 
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patients with CD4+ counts of less than 50 cells/µL because 15% of those 
patients with active CMV retinitis are asymptomatic.  
Differential diagnosis includes HIV retinopathy, toxoplasmosis, 
Candida, syphilis, herpes simplex retinitis, herpes zoster retinitis, and 
progressive outer retinal necrosis (PORN). Diagnosis is based on the history 
and the clinical appearance of a white, necrotic, enlarging retinitis, with or 
without hemorrhage, in a patient who is immunocompromised. 
ACUTE RETINAL NECROSIS4  
• Caused by many viruses especially VARICELLA ZOSTER  
• Triad of retinal Necrosis, severe vitritis and vasculitis  
• Disease starts as peripheral tongue shaped necrotic lesion and 
gradually invades the centre.  
Progressive outer retinal necrosis  
PORN, considered by some to be a variant of ARN, is another common 
retinopathy, occurring in 2% of patients with AIDS with CD4+ counts of 
usually less than 50 cells/µL. Peripheral outer retinal necrosis sparing the 
perivascular retina occurs in a circumferential pattern. These lesions coalesce in 
weeks and progress to full-thickness retinal necrosis. Posterior progression 
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occurs with minimal inflammation. Visual deterioration to no light perception 
occurs within weeks. The fellow eye can be involved in weeks to months.  
Differential diagnoses include CMV and toxoplasmosis retinitis. Neither 
spreads so quickly in a circumferential pattern nor spares the perivascular 
retina. A clinical diagnosis is made with the appropriate history and the 
characteristic fundus findings. Diagnosis can be confirmed via PCR on aqueous 
humor samples or histopathologic and/or immunohistochemical stains on retinal 
biopsy specimens obtained from the patient.  
No effective therapy is available. Intravenous ganciclovir and/or 
foscarnet given simultaneously with acyclovir may stabilize the infection and 
delay progression. Intravitreal ganciclovir and foscarnet also have been used 
with limited success.  
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RETINAL VASCULITIS AND AUTOIMMUNE DISEASE 
 
BEHCETS DISEASE54  
Behcet’s disease is a multisystem chronic inflammatory disorder, 
presenting classically with recurrent orogenital ulcers and ocular and skin 
manifestations. Hypopyon uveitis is the commonest presentation.  
 
 Retinal vasculitis major cause of visual morbidity, relapses are frequent, 
leading finally to retinal and optic dystrophy, variable chorio retinal and retinal 
pigment epithelial changes, sheathed vessel, chronic mild vitritis.  
 
 Yellow white retinal infiltrate are specific not in other idiopathic retinal 
vasculitis. Recurrent BRVO is common. 
 Loss of vision is usually after 3 years onset of disease.  
 
HLA- B27 associated 19,56  
Acute Fibrinous anterior uveitis is the most common ocular 
manifestation of HLA-B27- associated uveitis. If the inflammation is not 
controlled quickly and adequately, it may result in retinal vasculitis with 
multiple diffuse foci of retinal infarcts, intraretinal hemorrhages, chronic 
vitritis, disc swelling, and macular, edema. Retinal vasculitis may not be 
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clinically apparent, but FFA may disclose peripheral venular vein occlusion 
with secondary disc neovascularization and marked visual loss can occur.  
Human leukocyte antigen is frequently present in patients with 
ankylosing spondylitis. Reiter’s syndrome and psoriatic arthropathy. The retinal 
vasculitis often responds to periocular steroid injections or high doses of 
systemic steroids.    
 
BURGERS DISEASE  
 Arterial wall infiltrate with polymorphonuclear leukocyte, and 
lymphocyte and inflammation extends into surrounding tissue involving the 
veins. Fibrosis and proliferation of intima full and lumen obliterated with 
thrombosis. Periartiritis of retinal vessels results in obliterate end arteritis with 
thrombosis vessels eventually become sheathed appear as white strands.  
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SARCOIDOSIS53,58  
- 27-30 % Ocular involvement  
- Idiopathic Granulomatosis disorder of protein 
manifestation  
- Periphlebitis as CANDLE WAX  DRIPPINGS – not 
pathogonomic  
- Focal and segment involvement of small vein near 
equator, hemorrhages, sub retinal infiltrates with RPE 
atrophy is common.  
Treatment  
 Systemic Corticosteroid resolves with residual sheathing, responds to 
pan retinal laser photo coagulation.  
 
SYSTEMIC LUPUS ERYTHAMOTSUS  
 Retinopathy most ocular complication of SLE as mild small vessel 
disease manifest as multiple cotton wool spots and intra retinal hemorrhage. 
CWS is hallmark of SLE in contrast DM, HT arteriolar dilation rather than 
constriction.  
 
 Vessel occlusion is caused by true vasculitis with perivascular 
inflammatory sheathing. This is not true vasculitis, caused by non vascular 
occlusion, not associated with an inflammatory cell infiltrate and is seen 
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clinically as CWS. Micro vascular occlusion immune complex, these may 
penertrate vessel wall as in choroids than an intense inflammatory reaction 
occur. Large vessel occlusion uncertain, but they may be initiated by lupus anti 
coagulant, anti cardiolipin antibodies are antiendothelial anti bodies.  
 
 Regression induced by pan retinal scatter laser photo coagulation.  
 
WHIPPLES DISEASE  
 
 Is a multi system inflammatory disorder that mainly affects men in 5th 
decade. Intra ocular involvement rare but uveitis, retinal vasculitis and retinal 
hemorrhage, capillary non perfusion vitreous hemorrhage, and papilledema can 
occur.  
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RETINAL VASCULITIS SECONDARY TO MALIGNANCY  
CANCER ASSOCIATED RETINOPATHY  
 Uncommon para neoplastic condition that develops in patient with 
neoplasia remote from the eye, typically small cell lung cancer patient present 
with visual loss and progressive night blindness and examination reveals 
attenuated Retinal vessel.  
 
 Retinal phlebitis seen in small cell lung cancer with perivascular 
sheathing, staining of vessel wall in FFA, no inflammatory cells were 
identified. It is an auto immune condition with circulating antibodies to retinal 
cells.  
 
OCULAR LYMPHOMA  
 
 Presents as chronic uveitis, manifest as subretinal plaque, retinal 
infiltrate, hemorrhages retinal vasculitis and retinal pigment epithelial 
infiltrates.  
 
 Tumor cells are clustered in perivascular region of retina, there is 
destruction of pigment epithelium and bruchs membrane.  
 Poorly responds to steroid.  
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DIFFERENTIAL DIAGNOSIS 
 
Based on Age Group52  
 
4yrs Toxo plasmosis, Masquarade syndrome   
5-15yrs 
Toxo Plasmosis, sympathetic opthalmia, CMV 
retinititis, leptospirosis  
16-40 Yrs 
Leptospirosis, Sarcoidosis, Behcets, VKH 
syndrome, sympathetic ophthalmia, candida. 
40 Yrs 
Leptospirosis, CMV retinits, Acute Retinal 
Necrosis, progressive outer retinal necrosis, 
tuberculosis, candida.  
AIDS (Any Age group) 
Cytomegalo virus retinitis, Acute Retinal 
Necrosis, progressive outer retinal necrosis, 
tuberculosis, candida   
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INVESTIGATION 
 
 Key to diagnose retinal vasculitis as in all medical condition lies in 
accurate and relevant history numerous studies showed that little additional 
information is gained by blind investigation of patients and pursuing this is 
neither time nor cost effective. Investigation specific to eye like Fundus 
fluorescein angiography is most useful to point the underlying pathology.      
1. Slit lamp examination and indirect Ophthalmoscopy  
2. Fundus fluorescein angiography –  
-    Most useful to point to the underline diagnosis  
- Used in assessing the  
(1) Integrity and density of retinal pigment epithelium  
(2) Permeability and perfusion of retinal vessels  
(3) Presence of neovascularisation  
(4) Extent of disc swelling 
(5) Helpful in management  
FFA .5ml 10% Na fluorescein intravenous  
 After 10-15 seconds faint patchy regions in choroids  
 With 3-5 minutes dye equally distributed throughout the body  
 With in 1hour whole dye eliminated  
 Excitation wave length 465nm blue light emits 525nm yellow green .  
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Fluorescein leakage43  
Arteriolar leakage in the presence of intra ocular inflammation is usually 
due to viral or protozoal infection although retinal arteries may be involved in 
systemic vasculitis such as systemic lupus erythematosus or wegeners 
granulomatous this usually leads to occlusion rather than leakage and 
intraocular inflammation is not a feature of these diseases. Leakage from retinal 
capillaries alone may occur in syphilis and whipples disease Leakage from post 
capillary and larger venules. However the most common pattern of retinal 
vasculitis such as leakage may be focal as seen in sarcoidosis or multiple 
sclerosis or more diffuse as seen in idiopathic retinal vasculitis, multiple 
sclerosis and B 27 associated posterior segment. 
 
Macular edema  
This is major cause of visual loss in posterior uveitis and potentially 
reversible and characteristically there is dilation of perifoveal capillary arcade 
early in FFA with accumulation of dye in cystic space with in retina later on. 
The degree of associated retinal thickening detected either clinically or by FFA 
is a good predictor of Visual acuity. Leakage of dye from optic nerve head 
arises from dilated capillaries and may be either to the primary infiltration or 
secondary vascular changes induced by intraocular inflammation.  
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Capillary Closure            
 Three pattern of retinal ischemia may be identified by FFA. Peripheral 
capillary closure is feature of tuberculosis, sarcoidosis, and idiopathic retinal 
vasculitis. Ischemic branch retinal vein occlusions are characteristic of Behcet 
syndrome and have also been reported in sarcoidosis. Focal capillary dropout at 
the fovea is often missed because of either media opacity or a failure to identify 
the fovea at appropriate phase of angiogram. This is an important sign because 
in presence of unexplained poor visual out come despite adequate suppression 
of disease. The ability to identify retinal vasculitis an ischemic by FFA has 
important implication for management.  
 
Neovascularization         
 Both neovascularisation disc and neovascularisation elsewhere, 
choroidal new vessel leak flourescein profusely in late phase of FFA. 
Neovascularisation may occur secondary to wide spread capillary closer are as 
a direct consequence of intraocular inflammation. It is important to identify the 
presence or absence retinal ischemia in this situation because management is 
different. In former case photocoagulation may be indicated as in later immuno 
suppression will usually induced regression of neovascularisation response.       
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SPECIFIC INVESTIGATIONS42 
Suspected Disease    Investigation  
Idiopathic Retinal vasculitits  FFA 
Sarcoidoisis    Full blood count, GALLIUM SCAN  
Liver function test, CT, CHEST                       
X-ray, S.ACE Biopsy    
Behcets disease    Skin test  
Multiple sclerosis   MRI, CSF, Analysis, VEP  
Systemic Vasculitis    ANA, Anti Neutrophil cytoplasmic antibody,  
     Erythrocyte Sedimentation Rate, C- reactive  
     protein   
Tuber culosis   Polymerase Chain reaction from aqueous and  
  vitreous samples biopsy  
Leptospirosis    Polymerase chain reaction, Micro  
     Agglutination titre Toxo plasnosis  
     Serology ELISA, DYE test  
Syphillis     FTA- ABS test, TPHA test  
Viruses   Respective serological titres and Polymerase 
Chain reaction  
Malignancy     Full blood count, biopsy CXR, CT scan,  
ocular biopsy for Histopathology   
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MANAGEMENT 
 
Before embarking on any form of therapy certain point need to addressed 
they are  
 Every efforts made to arrive at diagnosis, especially when 
dealing with infection and malignant lesion  
 Consideration given off treatment needed, as Eale’s and par’s 
planitis resolved on its own 
 Consider the duration, Risk – Benefit ratio of therapy 
 Rule out any irreversible cause of visual loss 
 
Corticosteroids  
It remains the main stay of treatment and may be administered topically, 
regionally or systemically usually by mouth, but also by Intra venous pulse 
therapy.  
 
Oral prednisolone: 80mg for 4 days than  
Follows 60mg for next 14 days  
40mg- one month and taper there after according to clinical 
response.  
 
 
 47
Periocular steroid: 
 Effects apparently with in 3weeks and lost for 3months  
 Triamnicolone di acetate (25mg/ml)  
Hydrocortisone acetate (25mg/ml)  
Posterior subtenon injection most preferred  
Frequent IOP monitor is essential   
 
Systemic immuno suppressive 
It is indicated when:   
 No response to maximum steroid therapy  
 Bilateral disease  
 When Visual Acuity decrease by  6/12   
Drugs  Dosages  
Methotraxate 7.5 – 15mg/week. 
Cyclosporin A starting dose 2.5 5mg /kg/day od. 
FK506 0.10 – 0.15 mg/kg/day 
Chlorambucil 0.1 – 0.2mg/kg/day 
Azathioprine  50 – 150 Mg/day 
Cyclophosphamide  50-150 mg/day 
 
LASER IN RETINAL VASCULITIS58  
 Mainly indicated in persistent neovascularization causing vitreous 
hemorrhage.  
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 In India laser used for eales disease 
Burns are placed in retinal vascularisation, capillary non perfusion micro 
aneurysm, and AV shunt vessels.  
 Direct treatment of laser spot of moderate Intensity (200-500 micron 
diameter). Elevated new vessels are treated by coagulation of feeder vessel. 
 
VITRECTOMY42   
 In recurrent vitreous hemorrhage, vitrectomy is indicated. The objective 
is to remove the vitreous hemorrhage in posterior phase, other surgical 
procedure Lensectomy, Epiretinal Membrane removal, Endolaser and 
Cryotherapy with Scleral Buckling.  
 
Recommended Treatment Protocol26 
  Patient with idiopathic retinal vasculitis do not necessarily require 
treatment those with sight threatening complications are started on regime 
designed to minimize total dose of steroids. 
1) Acute Stage: Systemic steroids are started as 0.5 – 1 mg/kg/day. 
Occasionally intra venous pulse methyl prednisolone 1gm/day for 
3 days. 
2) Long term control: To allow steroid dose to be reduced, low dose 
cyclosporine therapy 5mg/kg/day is given. After 3-6 weeks when 
control has been achieved dose of systemic steroid is tapered and 
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discontinued. Monotherapy with cyclosporine or combination 
therapy with low dose steroid can be continued for months/ yrs if 
necessary. 
3) Additional Immunosuppression: Other drugs are required if 
inflammation persist despite cyclosporine and low dose steroid a 
variety of agents can be used in combination or as alternative to 
the maintenance regime. In certain special instances of patients 
with specific diagnosis such as Wegener’s will require additional 
immuno suppression to control life threatening complication of 
systemic disease.  
 
Patient who are not responding to therapy also receive the attention of 
specialists to exclude rare inflammation or malignancy. This is may require 
unusual investigation that are not routinely available.       
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REVIEW OF LITERATURE 
 
George et al primary retinal vasculitis; Ophthalmology, Volume 103, 
Number 3, March 1996 evaluated 25 patients of primary retinal vasculitis. 525 
were male and 48% female. The mean age of patients at baseline was 34 years. 
All patients were bilateral at presentation. The most common finding was 
vascular sheathing (64%) followed by retinal neovascularisation (40%) sclerotic 
or attenuated vessels (32%) intra retinal hemorrhage (36%) vascular occlusion 
(20%) and vitreous hemorrhage (23.1%) vitreous cells are noted in 80%. 
 
Graham EM. Stanford MR, Sanders MD, et al. A point prevalence study 
of 150 patients with idiopathic retinal vasculitis: 1. diagnostic value of 
ophthalmological features. Br. J. Ophthalmol. 1989; 73 714-721. Studied 67 
patients of isolated retinal vasculitis and 83 patients of retinal vasculitis 
associated with systemic inflammatory diseases. Out of 67, 27 patients were 
male and female 72% in age group between 15-40 yrs. Most prevalent finding 
were sheathing of peripheral retinal vessels in 2/3rd of patients, 
neovascularisation (16%). 
 
Features of 83 patients with retinal vasculitis and systemic inflammatory 
disease: 44 patients were made and 39 were female. 61% between age group of 
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15-40 yrs. Ophthalmological features different according to the nature of 
systemic inflammatory disease.  
 
In Pakistan Journal ophthalmology, idiopathic retinal vasculitis account 
49%, inactive tuberculosis retinal vasculitis 27.9% by Dr.Mohamed Sakh 
Nemon, Shabrol Jaman Siddiqu, Syed. Apr 2004 (2) 53-56.  
 
Vestn Oftalmol. 2001Jul-aug; 117 (4):36-8 Conservative therapy of 
isolated retinal vasculitis. Ermakova NA. Improvement of visual acuity was 
more pronounced in patients treated by steroid pulse therapy than in those 
treated orally and peribulbar. Reabsorption of retinal perivascular exudate was 
sooner achieved by steroid pulse therapy than by oral treatment.  
 
Gupta et al tuberculosis retinal vasculitis: Retina the Journal of Retinal 
and vitreous disease 2001 Volume 21 number 5, page 435-444, Evaluated 
polymerase chain reaction positive tuberculosis retinal vasculitis. 69.2% male 
and 30.7% were female mean age group of 20 years bilateral in a 9 cases out of 
13 cases. The most consistent finding was the presence of vitritis in all eyes. 
Followed by snow ball opacities in (89.4%) neovascularisation (57.8%) focal 
Choroiditis (47.3%) vitreous / preretinal hemorrhage (26.3%) and serous retinal 
detachment in 15.7% over a median follow up of 12 months all showed 
resolution of vasculitis with no recurrences.  
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Indian Journal Tuberculosis 2001, 48, 143. Tubercular Etiology in cases 
of retinal vasculitis*, S.P.Rai, B.N. Panda, V.S. Gurunath and P.K. Sahoo. 
 
A total of 44 cases of retinal vasculitis admitted in the tertiary care centre 
of the Armed Forces, between January ’98 and June 2000, were evaluated 
prospectively for evidence of healed or active tuberculosis in the body. Retinal 
vasculitis was bilateral in 28 and unilateral in 16 patients, all were males; the 
average age was 31.7 years (range 16 to 53 years); only 2 patients had 
constitutional symptoms and no patient had past history of tuberculosis.  
 
Retinal disease in patients with systemic lupus erythematosus, Osamu 
Ushiyama, Keiko Ushiyama, syuichi Koarada, Yoshifumi Tada, Noriaki 
Suzuki, Akihide Ohta, Shinji Oono, Kohei Nagasawa. The findings included 
haemorrhages, vasculitis, cotton wool spots, and hard exudates, all of which 
were considered to reflect vascular damage.        
 
American Journal Opthalmol 1998: 125:312-324. Ralph D. Levinson 
MD, Robin Vann MD, Janet V. Davis MD, Dorothy N. Fried Berg MP, PhD., 
Adnan Tufail MBBS, Frcophth, Briant, Terry MD, Jannete I, Lindley MD 
FRCS (C) and Gary N. Hollan, MD.  HIV patients with complaints floaters and 
blurred vision seen with significant inflammatory sheathing of peripheral retinal 
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venules minimal vitritis and typical retinal lesions were gray-white to yellow 
irregular in shape, located in mid periphery of retinal fundus. 
 
Malinowski et al, Long term visual outcome and complication associated 
with pars planitis, Ophthalmology 100, 818-825; 1993. Report the complication 
on 54 patients. Most commonest cause of visual loss is cystoid macular edema 
(50.9%), followed by cataract (41.4%), neovascularisation (6.5%), severe 
cellophane retinopathy (6.5%) and retinal detachment (8.3%).  
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AIM OF THE STUDY 
 
 
 
 To determine the various etiological pattern of retinal Vasculitis 
 
 
 To determine the various ophthalmoscopic features at 
presentation. 
 
 
 To assess visual outcome in various etiological retinal Vasculitis  
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MATERIALS AND METHODS 
 
 It was a prospective study of patients who attended the retina and uvea 
service at Ophthalmology Department Government Rajaji Hospital Madurai. 
 
All cases of Retinal Vasculitis were taken up for study, irrespective of 
other ocular or systemic manifestation. 
 
A standard proforma was used to collect and document all the details 
regarding the cases included in the study. 
 
 The detailed information regarding history and specific questions about 
presence of possible multisystem inflammatory disorders were asked.  
 
History of  
orogenital ulcerations and skin rash (Behcet’s syndrome),  
recent weight loss, dry cough, night sweats, arthralgia (sarcoidosis) 
neurological symptoms (Multiple sclerosis and sacoidosis),  
arthritis (sero negative arthropathies),  
and recent changes in bowel habits.  
 
The absence of any diagnostic clues from history makes idiopathic 
retinal vasculitis most likely.  
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The diagnostic criterion of retinal vasculitis was made atleast one of the 
following ophthalmoscope features.  
1) Sheathing  
2) Perivascular Edema 
3) Perivascular inflammation 
4) Staining of vessel wall in FFA. 
 
Retinal arteries involvement is almost always due to systemic vasculitis 
or viral retinitis, capillary involvement occurs in syphilis and whipples. Retinal 
vein involvement occurs in sarcoidosis, Behcets, Multiple sclerosis, 
inflammatory bowel disease. Intra retinal infiltrates are characteristics of 
infectious process. Cotton wool spots in systemic vasculitis. Swelling of optic 
nerve head is a common non specific finding related to intra ocular 
inflammation.    
After collecting detailed information regarding history and complaints, a 
thorough examination of anterior segment was done with slit lamp. Intraocular 
pressure recorded with schiotz tonometer. Gonioscopy was done routinely for 
all cases. Retinoscopy was done with or without clear media to assess refractive 
status.   
 For examination of posterior segment all the cases were subjected to 
dilated ophthalmoscopic evaluation with fundus lens and indirect 
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ophthalmoloscopy. Fundus Flourescien Angiography was done in appropriate 
cases. 
 All cases were subjected to following lab Investigations  
1. Haemogram – Total count, Differential count, Erythrocyte 
sedimentation rate. 
2. Urine albumin sugar 
3. Mantoux  
4. Blood VDRL 
5. Blood sugar 
6. Bleeding time / clotting time  
 
All the cases were referred to the following departments attached to our 
Govt. Rajaji Hospital Madurai 
1. Rheumatology clinic 
2. Ear nose throat clinic 
3. Dermatology Department  
4. Chest clinic 
5. Sexually Transmitted Disease department  
6. Neuro medicine Department 
7. Dental Department  
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Diagnosis was based mainly on history, ophthalmoscopic findings at 
presentation; clinical features are correlated with the results of various 
investigations at presentation. 
 
In the absence of systemic history and inconclusive laboratory 
investigation, ophthalmoscopic finding suggesting primary involvement of 
retinal vessels with significant vitritis are grouped as idiopathic or primary 
retinal vasculitis.      
 
PRIMARY RETINAL VASCULITIS  
1. For cases with peripheral Vasculitis and good visual Acuity with no 
Evidence of retinal non-perfusion, periodic observation was made. 
 
2. For cases with peripheral vasculitis and good visual Acuity with 
evidence of less than 5 DD retinal non perfusion, systemic steroids, 
prednisolone 60mg/day in divided dose for a period of 2 weeks were 
given then tapered. Then periodic review was advised. 
 
3. For cases with peripheral Vasculitis associated with a relative non 
perfusion of more than 5 DD, retinal photocoagulation was advised. 
 
4. For cases of vitreous hemorrhages with neo vascularization and some 
amount of clear media laser photocoagulation was advised.    
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5. For cases of vitreous haemorrhage were advised observation and regular 
follow up. In cases of Vitreous haemorrhage with opaque media and 
evidence of tractional bands in Ultrasonography transconjunctival 
cryopexy was advised. If vitreous hemorrhage did not resolved with in 6 
months vitrectomy was opted.  
 
6. For cases of tractional Retinal detachment vitrectomy with 
Endophotocoagulation was advised          
 
SECONDARY RETINAL VASCULITIS 
 For cases of Vasculitis secondary to ocular and systemic disorders 
management was directed towards associated condition.  
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RESULTS AND OBSERVATION  
 
 This prospective study of 41 patients Retinal Vasculitis were analysed as 
follows  
A. Distribution of etiology 
 In this study of 41 cases  
Diseases Cases Percentage 
Retinal Vasculitis of known etiology  22 53.65 
Tuberculosis  10 24.39 
Human Immuno deficiency Virus  7 17.07 
Systemic lupus erythematosus 4 9.75 
Pars Planitis   1 2.43 
Idiopathic Retinal Vasculitis 19 46.34 
Total  41 100 
 
 In this study retinal vasculitis of known etiology accounts for 53.65% 
(22 cases) and unknown etiology retinal vasculitis of 46.34% (19 cases). 
 
Commonest cause of retinal vasculitis in this study was associated with 
idiopathic retinal vasculitis 19 cases (46.34%). Other major causes are 
Tuberculosis (24.39%), Systemic lupus erythematosus 4 cases (9.75%) 1 
(2.43%) case of Intermediate uveitis and 7 (17.7%) cases of Human Immuno 
deficiency Virus positive.      
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B. Sex Incidence of retinal vasculitis  
  
In this study a slight male preponderance (58.53%) is in compare to 
female 41.46% Murphy et al noted equal Involvement among men and women. 
Idiopathic retinal vasculitis, tuberculosis has a significant male proportion, 
where as systemic lupus erythematosus predominant in female.     
 
C. Age Distributions  
Sex 
Idiopathic 
Retinal 
Vasculitis 
Tuber 
culosis 
Systemic 
lupus 
erythemat
osus 
Human 
Immuno 
deficiency
virus  
positive 
Pars 
planitis 
Percent
age 
Male  11 7 1 4 1 58.53 
Female  8 3 3 3 - 41.46 
Age 
group 
Idiopathic 
Retinal 
Vasculitis 
Tuber 
culosis 
Systemic lupus 
erythematosus
Human 
immuno 
deficiency virus 
Pars 
planitis
<20 4 - - - - 
21 – 30 8 2 2 5 - 
31-40 5 4 2 2 1 
>40 yrs 2 4 - - - 
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 Most cases of retinal vasculitis occurred between second and third 
decade of life. In this age group our study of idiopathic retinal vasculitis around 
(68.4%) and tuberculosis (60%).      
 
D. Laterality  
 Cases Percentage  
Unilateral  18 43.90 
Bilateral  23 56.09 
 
Among 41 cases of RV 23 cases (56.09%) were bilateral. Most cases of 
retinal vasculitis are initially presents unilateral, over a period of time it 
developed into bilateral. 
E. Mode of presentation    
 
 
 Acute onset is 19 (46.34%) cases chronic onset around 19 (46.34%) 
cases idiopathic retinal vasculitis has equal proportion of onset. Where as 
tuberculosis and virus related retinal vasculitis are acute onset.  3 cases were 
asymptomatic.      
Onset 
Idiopathic 
Retinal 
Vasculitis 
Tuber 
culosis 
Systemic lupus 
erythematosus 
Human 
immuno 
deficiency virus 
Pars 
planitis
Acute 10 7 0 2 - 
Chronic 9 3 3 3 1 
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SYMPTOMS  
 Symptoms of 64 eyes studied as follows 
  
 
Defective vision is the commonest complaint of patients account for 
35.9%. HIV patient has complaints of floaters mainly. One case of systemic 
lupus erythematosus and two cases from antiretroviral center referred for 
routine fundus examination were asymptomatic. Pans planitis has complaint of 
photophobia and floaters.      
 
 
Symptoms 
Idiopathic 
Retinal 
Vasculitis 
Tuber 
culosis 
Systemic lupus 
erythematosus 
Human 
immuno  
deficiency 
virus 
Pars 
planitis
Defective vision 12 6 3 2 - 
Floaters  2 2 1 4 1 
Redness  1 3 - - - 
Pain  1 1 - 2 - 
Photophobia  - - - 0 1 
A symptomatic  - - 1 2 - 
All of the above  3 1 - - - 
 64
POSTERIOR SEGMENT FINDINGS AT PRESENTATION  
 
 
Symptoms 
Idiopathic 
Retinal 
Vasculitis 
Tuber 
culosis 
Systemic lupus 
erythematosus 
Human 
immuno 
deficiency 
virus 
Pars 
planitis
Vascular sheathing  14 8 3 3 1 
Neo 
vascularisation  
8 3 - - - 
Intra retinal   
Haemorrhage 
6 2 3 0 - 
Sclerotic vessel  8 2 2 - - 
Cystoid  macular 
edema  
3 3 - 1 - 
Vitreous 
Haemorrhage 
6 1 - - - 
Vascular occlusion  - - 1 - - 
Retinal 
Detachment  
2 - - - - 
Vitritis   6 5 2 2 1 
Disc edema  - - - 2 - 
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In idiopathic retinal vasculitis posterior segment finding of vascular 
sheathing seen in 14 eyes (46.6%), neovascularisation 8 eyes (26.6%), vitreous 
hemorrhage 6 eyes (20%). 
 
 In tuberculosis retinal vasculitis sheathing 50% of eyes are involved. In 
systemic lupus erythematosus patient shows cotton wool spot, hard exudate, 3 
eyes of perivascular sheaths and 3 eyes with intra retinal hemorrhage. 
 
 In pars planitis, peripheral vascular sheathing is present and with 
significant vitritis.  
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TREATMENT  
 In addition to specific treatment, corticosteroid was main stay of therapy 
in almost all cases of retinal vasculitis irrespective of etiology.  They were used 
by pulse therapy as I.V methyl prednisolone sodium succinate 1g daily for 3 
days then Prednisolone 1 mg/kg/day doses is given and then tapered gradually. 
Pulse therapy is not used in tuberculosis and human Immuno deficiency virus 
positive patients. Two cases of recurrent vitreous Hemorrhage referred to 
Vitreo retinal centre.  
 
One case of Tract ional bands and neovascularisation were advised for 
laser photocoagulation Human Immuno Virus positive and Systemic Lupus 
Erythematosus  referred to there respective clinics for further management 
which improves the visual acuity much better. In one case of pars planitis with 
retinal vasculitis regular follow up, no treatment given.    
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STATUS OF VISUAL ACUITY IN 64 EYES AFTER 6 MONTHS  
After 6 months 
Disease 
Improvement Static Deterioration 
Patient not 
turn over 
Idiopathic retinal vasculitis 6 6 14 4 
Tuber culosis  10 6 0 - 
HIV 2 1 5 1 
SLE 2 3 3 - 
Pars planitis  - 1 - - 
    
 Idiopathic retinal vasculitis shows improvement of two lines in 23.07% 
of eyes, static 23.07%, deterioration 53.8%, tuber culosis retinal vasculitis 
shows great improvement around 62.50% static about 37.5%. Human 
Immunodeficiency Virus shows visual deterioration in spite of HAART 
therapy. Systemic lupus erythematosus 37.5% of eyes shows visual 
deterioration, which indicates the severity of disease.       
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DISCUSSION 
 
 This study of 41 patients with retinal vasculitis is to assess the 
underlying etiology, to analyse the course of disease and to evaluate their visual 
outcome. 
 
 Most of published literatures were from West and there etiology most 
commonly, account for systemic auto immune disorder.  
 
In our study systemic lupus Erythematosus account for 9.75% and no 
Behcet’s disease. On a study of Pakistan Journal ophthalmology Idiopathic 
retinal vasculitis account 49% inactive tuberculosis retinal vasculitis 27.9% by 
Dr. Mohamed Sakh Nemon et al16. 
 
 In our study major etiological factor are primary or Idiopathic Retinal 
Vasculitis accounts for 46% and infectious, both tuberculosis and human 
immuno deficiency virus accounts for 41.46% other contributing factors are 
systemic disorders like systemic lupus erythematosus in 9.75% and pars planitis 
in one case.        
 
 Eales disease is also a diagnosis of exclusion and, a form of primary 
periphlepitis like isolated or primary retinal vasculitis, it becomes hard to 
separate the two entities But, currently Eales disease is considered to effect 
 69
multiple quadrants of the retina with progression of capillary drop out from 
periphery towards the posterior pole, and more over increased frequency of 
vestibulo auditory findings are seen in patients of Eales disease. While most of 
the patients of primary retinal vasculitis have diffused vasculitis and capillary 
drop out of both peripheral and central retina. However, with out a clear 
understanding of pathophysiology of two entities, it is certainly possible that 
they represent a continuation of similar disease process as by George et al31.   
 
 In 19 cases of idiopathic retinal vasculitis 57.8% were male and 42.10% 
female. Among which 13 cases in the age group of 20-40 years, most of cases 
were bilateral at presentation Posterior segment finding of idiopathic retinal 
vasculitis were vascular sheathing in 46.6% (14 eyes), vitreous hemorrhage in 
20% (6eyes), vitritis was significant, neovascularization disc, 
neovascularization elsewhere hallmark of idiopathic retinal vasculitis. 
 
 Visual acuity of 6 eyes shows improvement of more than 2 lines from 
Snellen chart using steroid alone. Using pulse steroid therapy reabsorption of 
retinal perivascular exudates was quicker than using oral steroid alone. 6 eyes 
vision remains static and 14 eyes shows vision deterioration.        
 
 George et al31 accounts for 64% of vascular sheathing, 
neovascularisation 46% vitreous hemorrhage 24%. 
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Second contributing factor for retinal vasculitis is infections due to 
tuberculosis and HIV. Tuberculosis retinal vasculitis in 10 cases, most cases 
shows some radiographic evidence of post pulmonary tuberculosis. 2 cases with 
mantoux positive, Age group around 20 – 40 yrs, bilateral, male with posterior 
segment findings shows vascular sheathing 50% moderate vitritis cystoid 
macular edema, neovascularization patient with anti tuberculosis treatment 
shows great improvement of visual acuity around 62.5%. In Gupta et al34 69.2% 
male and 30.7% were female mean age group of 20 years bilateral in a 9 cases 
out of 13 cases. The most consistent finding was the presence of vitritis in all 
eyes. Followed by snow ball opacities in (89.4%), neovascularisation (57.8%), 
focal Choroiditis (47.3%), vitreous / preretinal hemorrhage (26.3%) and serous 
retinal detachment in 15.7% over a median follow up of 12 months all showed 
resolution of vasculitis with no recurrences.  
 
 Incidence of Systemic lupus erythematosus in our study is 9.75% had 
features of vessel sheathing, narrowing or tortuous. In Ermakova NA et al15 
shows 34.5% retinal vascular abnormality (3%) retinal vasculitis with extensive 
peripheral capillary non perfusion and neovascularization.   
 
Referred patient as HIV positive with complaints of floaters and Blurred 
vision seen with significant inflammatory sheathing of peripheral retinal 
venules minimal vitritis and typical retinal lesions were gray-white to yellow 
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irregular in shape, located in mid periphery of retinal fundus. 55.5% visual out 
come is poor inspite of highly active antiretroviral therapy (HAART). 
 
Our study had one case of intermediate uveitis, with feature of peripheral 
retinal vein are dilated, segmental and tortuous with white sheath and small 
patches vein wall associated with minimal vitritis. Visual acuity is normal, no 
treatment is given and patient is on follow up.   
 
 Out of 41 cases 5 cases developed complicated cataract all had posterior 
subcapsular cataract may be due to steroid therapy or due to chronic 
inflammation.    
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CONCLUSION 
 
 With in the limitations of this study, examination of these 41 patients has 
shows, different pattern of retinal vasculitis. And it is mandatory for all cases of 
retinal vasculitis to be examined in detail in order to look for ocular 
involvement other systemic involvement and to do a complete work up of 
investigation procedures. This will certainly help to classify the retinal 
vasculitis. 
 
It is evident that when case of idiopathic retinal vasculitis are detected 
early and treated adequately the incidence of vision threatening complication 
are considerable minimized. Vasculitis associated with human Immuno 
deficiency virus had a worse outcome due to rapid progression despite therapy. 
 
More follow up period is necessary to describe the complications of the 
disease and also to analyze whether case of Idiopathic Retinal Vasculitis 
develop any systemic feature would lead on to a specific diagnosis.   
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ABBREVIATIONS 
  AIDS   -  Acquired Immunodeficiency Syndrome  
ANA  - Anti Nuclear Antibody    
BRVO  -  Branch Retinal Vein Occlusion  
BT  - Bleeding Time  
CMV   -  Cytomegalo Virus 
CRVO  -  Central Retinal Vein Occlusion  
CSF  - Cerebro Spinal Fluid  
CT Scan - Computed tomography 
CT  - Clotting Time  
CWS  - Cotton Wool Spots 
FFA   -  Fundus Fluorescence Angiography  
Govt  - Government  
HAART  -  Highly Active Antiretroviral Therapy  
HIV   -  Human Immunodeficiency virus  
LE  - Left Eye 
MRI  - Magnetic Resonance Imaging  
NVD   -  Neovascularisation Disc 
NVE   -  Neovascularisation Elsewhere 
RE  - Right Eye 
RVH  - Repeated Vitreous Hemorrhage  
SLE   -  Systemic Lupus erythematosus  
TB   -  Tuberculosis  
VEP  - Visually Evoked Potential  
VKH   -  Vogt Koyanagi – Harada Syndrome  
VDRL - Veneral Disease Research Laboratory 
PROFORMA 
 
I. PATIENTS RECORD  
Name   Age   Sex   Male /Female:  
Address     Outpatient Number 
II. COMPLAINT  
Laterality    RE  LE  BE 
 
Symptoms:   Defective vision    Duration 
   Floaters   Onset 
   Pain    Severity    
   Redness   Course 
       Any Previous attack  
          
Past Ocular History  
 Intra Ocular Inflammation  
 Prior Visual Loss -  Right eye/ Left eye  
 Miscellaneous  
 
SYSTEMIC HISTORY  
General  fever/malaise / loss of weight/loss of appetite   
Skin  Rashes / subcutaneous nodules / urticaria / edema / 
Raynaud phenomenon/ alopecia / ulcers  
Joints Arthritis / Arthralgia / Low back pain / Inflammatory 
signs. 
Pulmonary  Chronic cough   Hemoptysis  
Neurological   Headache / Thickened Nerves / Tinnitus.  
Renal  edema of  legs / puffiness of face / polyuria / oliguria  
 
H/O INTAKE OF DURGS  
Treatment history   On steroid    1  
   Not on steroid  2  
   Anti metabolites  3  
Ocular Examination : 
Laterality    LE  RE  BE   
Anterior segment   Granulomatosis  Non-granulomatosis  
Conjunctiva 
Nodules  
Lacrimal grand 
Sclera 
Cornea  
AC Reaction  Hypopyon / hyphema 
Iris 
Intra ocular pressure  RE  LE   
Posterior segment   Vitreous   Disc 
VASCULITIS PATTERN  
Arterioles     Segmental Vasculitis  
Veins      Diffuse Vasculitis 
Both      Occluded Vessel 
Capillaries     Sheathing 
Retinal infiltrate   Pars planitis  
Chorioretinal scar    Macular Edema  
Neo vascularization    Retinal Hemorrhage  
Choroidal Granuloma     Any Sequence  
Vitreous Hemorrhage  
SYSTEMIC FINDING  
INVESTIGATION  
Blood pressure       VDRL 
Urine: albumin, sugar     ELISA 
Hemoglobin        Toxo Igm 
Total count        Motion Ova/cyst 
Differential count        
BT / CT 
ESR 
Mantoux 
Chest X-ray  
Fundus flourescein Angiography    RE   LE 
Early – Hypoxic Area  New vessels disc and New vessels else where 
Late  - Hypoxic Area   RE   LE     
TREATMENT  
Steroid 
Immuno suppressive  
Surgery (vitrectomy) 
Others  
 
DIAGNOSIS  
FOLLOW –UP 
 
Date     Clinical Features     Remarks   
 
NORMAL FUNDUS 
 
 
 
 
 
NORMAL FUNDUS FLUORESCEIN ANGIOGRAPHY 
 
 
 
 
IDIOPATHIC RETINAL VASCULITIS 
 
 
 
 
 
 
 
 
 
VASCULITIS IN TUBERCULOSIS 
 
 
 
 
VASCULITIS IN CYTOMEGALO VIRUS 
 
 
 
FFA - STAINING OF VESSEL WALL IN 
RETINAL VASCULITIS 
 
 
 
FFA 
LEAKAGE DUE TO NEOVASCULARISATION 
 
 
 
 
 
 
 
 
 
 
NORMAL RETINAL MICROVASCULAR COMPONENTS 
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Improvement Static Deterioration Patient not
turn over 
Status of visual acuity in 64 eyes after 6 months
Idiopathic tuberculosis HIV SLE Pars Plaintis
 
 
RE LE RE LE
1 Palani Samy 22 M Def.vision A BE N N + 6/6 6/36 6/60 HM Ref. to vitreo retinal centre 
2 Karupasasumathy 18 F Floaters A LE N N + 6/6 6/12 6/6 HM
3 Saravanan 25 M Pain A LE HIV+ N 6/6 6/12 6/6 6/60 HAART
4 Sairam 44 M Def.vision A BE TB N + 6/12 6/9 6/12 6/9 On RNTCP
5 Kanchana 35 F Floaters C BE HIV + - - 6/18 6/36 6/12 6/12 HAART
6 Sankar 22 M Def.vision A BE TB N 6/18 6/18 6/9 6/18 RNTCP
7 Jayanthi 31 F Asymptomatic - BE SLE N - - 6/6 6/6 6/6 6/6
8 Rajamahamed 19 M Photophobia A RE N N 6/9 6/6 - - Patient not turn over
9 Rajamahamed 26 M  Def.vision C BE N 6/12 6/12 6/12 6/12
10 Muthulakshmi 48 F  Redness C LE TB N 6/36 6/36 6/9 6/9 RNTCP
11 Manikandan 33 M Def.vision A LE TB 6/9 6/36 6/9 6/9 RNTCP
12 Mariammal 37 M Pain, Def.vision C LE N N 6/6 6/9 6/6 6/24
13 Murugan 29 M Def.vision, pain, photophobia A BE N - 6/12 6/9
6/36 6/60
14 Alagurthevar 55 M redness + Def.vision C BE N N - 6/60 HM 6/60 6/12 PSCC
15 Famina 36 F Def.vision A BE TB N + 6/36 6/60 6/9 6/12 RNTCP
16 Amsavalli 26 F Redness C RE N N HM 6/6 - - Patient not turn over
17 Alagu 28 F  Def.vision C BE SLE Scleritis keratitis - - 6/24 6/24 6/36 6/60
18 Natarajan 31 M Redness A BE N N - 6/24 6/36 6/60 6/60 PSCC
19 Anbuselvi 40 F Def.vision C BE SLE N - - 6/24 6/36 6/24 2/60
20 Pondy 35 M Def.vision A BE TB N - - 6/36 6/36 6/9 6/9 RNTCP
21 Vadivel 33 M Floaters C RE HIV + - - 6/12 6/12 6/60 6/12 HAART
22 Rajeswari 23 F Pain + photo+ Def. vision A BE N N + - 6/12 6/6 - -
Ref.to vitreo retinal 
centre 
23 Papathy 38 F Def.vision C LE N N - + 6/12 6/18 6/12 6/60
24 Dhanapal 38 M Def.vision A BE N N - - 6/36 6/36 6/36 6/36 PSCC
25 Manikandan 25 M Def. vision C BE TB N - - 6/36 6/60 6/9 6/12 RNTCP
Master Chart
TREATMENT & 
FOLLOW UP NAME
ASSOCIATED 
OCULAR 
DISORDER 
VITREOUS 
HAEMMOR
HAGE
NEO 
VASCULARI
SATION 
INITIAL 
VISION
VISION AFTER 6 
MONTHS S.NO AGE SEX SYMPTOMS 
MODE 
OF 
ONSET 
LATERALITY SYSTEMIC DISORDER 
RE LE RE LE
TREATMENT & 
FOLLOW UP NAME
ASSOCIATED 
OCULAR 
DISORDER 
VITREOUS 
HAEMMOR
HAGE
NEO 
VASCULARI
SATION 
INITIAL 
VISION
VISION AFTER 6 
MONTHS S.NO AGE SEX SYMPTOMS 
MODE 
OF 
ONSET 
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26 Vijaya 35 F Redness C BE N N - - 6/12 6/9 6/36 6/60
27 Priya 24 F Asymptomatic - RE HIV + CMV retnitis - - 6/6 6/6 - - Patient not turn over 
28 Mr.Annadurai 34 M Def.vision C LE N Parsplanitis - - 6/6 6/6 6/6 6/6
Follow up & 
investigate for 
systemic disease
29 Sethu 41 M Def.vison C RE TB - + HM 6/12 HM 6/12 Mantoux +ve 
30 Vijay 15 M Def. vision A RE N N + - 1/60 6/12 PL 6/12 Ref.to vitreo retinal centre 
31 Sekar 27 M Def. vision C BE N N - - 6/36 6/18 6/60 6/60 PSCC
32 Murugan 30 M Def.vision C BE SLE - - 6/60 6/36 6/18 6/9
33 Geetha 22 F Floaters A BE HIV+ HIV+ - - 6/12 6/12 6/60 HM On HAART  
34 Latha 26 F Def.vision A BE N N + + HM PL 1/60 3/60 For vitrectomy 
35 Banu 33 F Redness  C BE N N - + 6/18 6/18 6/18 6/18
36 Ameer sasha 26 M floaters A RE TB - - - 6/12 6/6 6/12 6/6 Mantoux +ve 
37 Ravi 21 M Asymptomatic - LE HIV+ HIV+ - - 6/6 6/6 6/6 6/6 On HAART  
38 Anand 18 M floaters A RE HIV+ N + - 6/18 6/6 6/60 6/6 On HAART  
39 Manikam 48 M Def. vision C BE N N - + 6/60 1/60 6/24 6/12 PSCC
40 Chithamal 55 F Redness C BE TB - - + 6/36 6/60 6/36 6/12 Cataract surgery done
41 Mohan 28 M Def.vision A LE N N + - 6/6 HM 6/6 6/18
Mode of onset:  U - Unilateral 
A- Acute BE - Bilateral 
C- chronic sex: 
laterality M- Male 
F-Female HM - Hand movement 
PL - Perception of Light
RE-Right eye
LE-Left eye 
RNTCP-Revised National Tuberculosis Control Programme
PSCC-Posterior Sub Capsular Catract
Def. Vision - Defective Vision 
